An approach to generate a library of CHO cells expressing diverse HLA class II plus peptide complexes for identification of TCR-ligands by using CLIP-substituted invariant chains

一种生成表达多种 HLA II 类加肽复合物的 CHO 细胞文库的方法,用于通过使用 CLIP 取代的不变链鉴定 TCR 配体

基本信息

  • 批准号:
    08557027
  • 负责人:
  • 金额:
    $ 8.32万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

In order to understand pathogenesis of autoimmune diseases, it is important to identify ligands for T cell receptor (TCR) of autoreactive T cells. We developed a new system for delivery of an antigenic peptide to the MHC class II pathway, using the invariant chain (Ii). We designed CLIP-substituted human p33-form us in which either streptococcal M12p55-68 peptide or human 65 kDa glutamic acid decarboxylase (GAD65) p116-129 peptide was substituted for CLIP (class II associated invariant chain peptide). Similar to the wild-type Ii, the CLIP-substituted Ii was associated intracellularly with DR4 molecules. We examined the peptide presenting function of these constructs. Hamster CHO cell transfectants stably expressing M12/CLIP-substituted Ii gene together with HLA-DR4 gene could process and present M12p55-68 to a M12-peptide specific and DR4-restricted CD4^+ T cell clone to induce production of IFN-gamma. Even in the presence of 100 CHO cell transfectants in a well of 96-wells micriculture plate in which 3*10^4 CHO cells were accomodated, the T cell cloneproduced a significant ammount of IFN-gamma. Furthermore, CHO cells expressing stably with HLA-DR53 gene and transiently with GAD6S/CLIP-substituted Ii gene stimulated production of IFN-gamma in a HLA-DR53-restricted and GAD65 autoreactive T cell clone established from a Japanese patient with insulin-dependent diabetes mellitus. These results indicate that the peptides substituted for CLIP of Ii p323 bound to the groove of DR molecules in the same manner as CLIP and they were preferentially presented to the CD4^+ T cell clone in the absence of HLA-DM molecules. This system may prove useful for immunotherapy with DNA vaccines or for construction of a library of antigen presenting cells expressing diverse HLA class-II plus peptide complexes for identification of TCR-ligands and the latter research project is now on going.
为了了解自身免疫性疾病的发病机制,鉴定自身反应性T细胞的T细胞受体(TCR)的配体是重要的。我们开发了一种新的系统,用于将抗原肽递送到MHC II类途径,使用不变链(Ii)。我们设计了CLIP-取代的人p33-形式,其中链球菌M12 p55 -68肽或人65 kDa谷氨酸脱羧酶(GAD 65)p116-129肽取代CLIP(II类相关不变链肽)。与野生型Ii相似,CLIP取代的Ii在细胞内与DR 4分子结合。我们研究了这些构建体的肽呈递功能。稳定表达M12/CLIP取代的Ii基因和HLA-DR 4基因的CHO细胞转染子可以加工并将M12 p55 -68呈递给M12肽特异性和DR 4限制性的CD 4 ^+ T细胞克隆,以诱导IFN-γ的产生。即使在96孔威尔斯培养板的一个孔中有100个CHO细胞转染子,其中容纳3 × 10^4个CHO细胞,T细胞克隆也产生大量的IFN-γ。此外,稳定表达HLA-DR 53基因和瞬时表达GAD 6S/CLIP取代的Ii基因的CHO细胞刺激了从日本胰岛素依赖型糖尿病患者建立的HLA-DR 53限制性和GAD 65自身反应性T细胞克隆中IFN-γ的产生。这些结果表明,取代Ii p323的CLIP的肽以与CLIP相同的方式与DR分子的沟结合,并且它们在不存在HLA-DM分子的情况下优先呈递给CD 4 ^+ T细胞克隆。该系统可用于DNA疫苗的免疫治疗,或用于构建表达不同HLA-II类加肽复合物的抗原呈递细胞库,用于鉴定TCR配体,后者的研究项目正在进行中。

项目成果

期刊论文数量(196)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nishimura,Y.: "(Review) Modification of human T cell responses by altered peptide ligands:a new approach to antigen-specific modification" Internal Medicine. 37. 804-817 (1998)
Nishimura,Y.:“(评论)改变肽配体对人类 T 细胞反应的修饰:抗原特异性修饰的新方法”内科。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kira,J-I.: "Western vs.Asian types of multiple sclerosis:immunogenetically and clinically distinct disorders" Ann.Neurol.40. 569-574 (1996)
Kira,J-I.:“西方与亚洲类型的多发性硬化症:免疫遗传学和临床上不同的疾病”Ann.Neurol.40。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ito, H., Yamasaki, K., Kawano, Y., Horiuchi, I., Nishimura, Y., and Kira, J.: "HLA-DP-associated susceptibility to optico-spinal from of multiple sclerosis in the Japanese" Tissue Antigens. 52. 179-182 (1998)
Ito, H.、Yamasaki, K.、Kawano, Y.、Horiuchi, I.、Nishimura, Y. 和 Kira, J.:“日本人多发性硬化症的 HLA-DP 相关视脊髓易感性”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Inoue, R., Matsuoka, T., Kondo, N., Nishimura, Y., and Matsushita, S.: "Identification of Dermatophagoides Farinae-2-derived peptides and class II・HLA molecules recognized by T cells of atopic individuals." Int.Archs.Allergy Immunol.114. 354-360 (1997)
Inoue, R.、Matsuoka, T.、Kondo, N.、Nishimura, Y. 和 Matsushita, S.:“特应性个体 T 细胞识别的 Dermatophagoides Farinae-2 衍生肽和 II 类·HLA 分子的鉴定。 “Int.Archs.过敏免疫学.114. 354-360 (1997)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuoka, T., Kohrogi, H., Ando, M., Nishimura, Y., and Matsushita, S.: "Altered TCR ligands affect antigen-presenting cell responses : Up-regulation of IL-12 by an analogue peptide" J.Immunol.157. 4837-4843 (1996)
Matsuoka, T.、Korogi, H.、Ando, M.、Nishimura, Y. 和 Matsushita, S.:“改变的 TCR 配体影响抗原呈递细胞反应:类似肽上调 IL-12”J
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIMURA Yasuharu其他文献

NISHIMURA Yasuharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIMURA Yasuharu', 18)}}的其他基金

Development of new cancer immunotherapy aiming activation of both anti-tumor killer and helper T cells
开发新的癌症免疫疗法,旨在激活抗肿瘤杀伤细胞和辅助 T 细胞
  • 批准号:
    24300334
  • 财政年份:
    2012
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of cellular cancer immunotherapy by using humaniPS-cell-derived dendritic cells and ideal cancer-associated antigens
利用人PS细胞衍生的树突状细胞和理想的癌症相关抗原开发细胞癌症免疫疗法
  • 批准号:
    23650609
  • 财政年份:
    2011
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Investigation on the molecular mechanisms of antigen presentation and recognition.
抗原呈递和识别的分子机制研究。
  • 批准号:
    14370115
  • 财政年份:
    2002
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of tumor-specific antigens recognized by human T cells
人类 T 细胞识别的肿瘤特异性抗原的鉴定
  • 批准号:
    12213111
  • 财政年份:
    2000
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
THE DIVESITY IN ANTIGEN RECOGNITION AND RESPONSE OF ANTIGEN-SPECIFIC HUMAN CD4^+ T-CELL CLONES
抗原特异性人类 CD4^ T 细胞克隆的抗原识别和反应的多样性
  • 批准号:
    11557027
  • 财政年份:
    1999
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of TCR/HLA/ peptide interaction and investigation of etiology of autoimmune diseases
TCR/HLA/肽相互作用分析及自身免疫性疾病病因学研究
  • 批准号:
    11694294
  • 财政年份:
    1999
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
ANALYSIS OF AUTOANTIGENIC PEPTIDE-HLA CLASS II COMPLEXES ASSOCIATED WITH AUTOIMMUNE DISEASES
与自身免疫性疾病相关的自身抗原肽-HLA II 类复合物的分析
  • 批准号:
    09470097
  • 财政年份:
    1997
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
IDENTIFICATION AND PREDICTION OF T-CELL EPITOPES BY USING HLA CLASS II-BINDING PEPTIDE MOTIFS
使用 HLA II 类结合肽基序识别和预测 T 细胞表位
  • 批准号:
    06454222
  • 财政年份:
    1994
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effects of polymorphism of HLA on binding of antigenic peptides to HLA and recognition of peptides complexed with HLA by T cell receptor
HLA多态性对抗原肽与HLA结合及T细胞受体识别HLA复合肽的影响
  • 批准号:
    03452276
  • 财政年份:
    1991
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Production of monoclonal antibody specific to HLA by utilizing HLA transgenic mice.
利用 HLA 转基因小鼠生产 HLA 特异性单克隆抗体。
  • 批准号:
    01870026
  • 财政年份:
    1989
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research

相似海外基金

Development of knowledge-based method for prediction of antigenic peptide binding to HLA
开发基于知识的预测抗原肽与 HLA 结合的方法
  • 批准号:
    19K07029
  • 财政年份:
    2019
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immunization with a Novel Single Cycle Flavivirus Particle Vector and Antigenic Peptide Nanofibers as a Prime-boost Vaccine Strategy against HSV-2
使用新型单周期黄病毒颗粒载体和抗原肽纳米纤维进行免疫作为针对 HSV-2 的初免-加强疫苗策略
  • 批准号:
    8873100
  • 财政年份:
    2015
  • 资助金额:
    $ 8.32万
  • 项目类别:
Control of cellular immunity by multi-step antigenic peptide delivery using peptide nano-needles
使用肽纳米针通过多步抗原肽递送控制细胞免疫
  • 批准号:
    24700479
  • 财政年份:
    2012
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
PROBING BINDING OF ANTIGENIC PEPTIDE TO MHC BY H & D EXCHANGE
H 探测抗原肽与 MHC 的结合
  • 批准号:
    7180029
  • 财政年份:
    2005
  • 资助金额:
    $ 8.32万
  • 项目类别:
Structural studies of the mechanisms for antigenic peptide binding of MHC class I molecule
MHC I 类分子抗原肽结合机制的结构研究
  • 批准号:
    16590032
  • 财政年份:
    2004
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of class II MHC bound antigenic peptide in the pathogenesis of inflammatory bowel disease.
II 类 MHC 结合抗原肽在炎症性肠病发病机制中的作用。
  • 批准号:
    15590676
  • 财政年份:
    2003
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
PROBING BINDING OF ANTIGENIC PEPTIDE TO MHC BY H & D EXCHANGE
H 探测抗原肽与 MHC 的结合
  • 批准号:
    6976984
  • 财政年份:
    2003
  • 资助金额:
    $ 8.32万
  • 项目类别:
PROBING BINDING OF ANTIGENIC PEPTIDE TO MHC BY H & D EXCHANGE
H 探测抗原肽与 MHC 的结合
  • 批准号:
    6665895
  • 财政年份:
    2002
  • 资助金额:
    $ 8.32万
  • 项目类别:
Application of Heat-shock protein with antigenic peptide for cancer vaccine
热激蛋白抗原肽在癌症疫苗中的应用
  • 批准号:
    14571146
  • 财政年份:
    2002
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
PROBING BINDING OF ANTIGENIC PEPTIDE TO MHC BY H & D EXCHANGE
H 探测抗原肽与 MHC 的结合
  • 批准号:
    6486775
  • 财政年份:
    2001
  • 资助金额:
    $ 8.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了